Physician profile
David E Hall
NPI 1043202583
$2,491.37
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $50.24 · 2021: $687 · 2022: $581 · 2023: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $858.51 | 2019-2023 | Argos, Clareon |
| Allergan, INC. | $390.32 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $275.74 | 2021-2023 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $167.72 | 2019-2021 | |
| Abbvie INC. | $105.62 | 2022-2023 | |
| Ani Pharmaceuticals, INC. | $95.27 | 2023 | Purified Cortrophin Gel |
| Ocular Therapeutix, INC. | $89.69 | 2022-2023 | Dextenza |
| Johnson & Johnson Surgical Vision, INC. | $87.20 | 2019-2023 | Tecnis Iol |
| Eyevance Pharmaceuticals LLC | $68.92 | 2019-2022 | |
| Oyster Point Pharma, INC. | $65.20 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $51.28 | 2021 | |
| Sun Pharmaceutical Industries INC. | $44.30 | 2021-2022 | |
| Rxsight INC | $42.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.86 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $41.65 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $22.43 | 2023 | |
| Shire North American Group INC | $21.55 | 2019 | |
| Ivantis, INC | $15.60 | 2021 | |
| Tearlab Corp | $5.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.